메뉴 건너뛰기
Hepatobiliary and Pancreatic Diseases International
Volumn 2, Issue 3, 2003, Pages 334-337
Non-alcoholic fatty liver disease: The problems we are facing
Author keywords

Insulin resistance and genetic study; Non alcoholic fatty liver disease
Indexed keywords

ALPHA TOCOPHEROL; ATORVASTATIN; BETAINE; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; FATTY ACID; GEMFIBROZIL; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIMVASTATIN; TETRAHYDROLIPSTATIN; UNCOUPLING PROTEIN 2; URSODEOXYCHOLIC ACID;
EID: 0041409910     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (12)
References (13)
  • 1
    • 0032171686 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
    • James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J hepatol 1998;29:495-501.
    • (1998) J. Hepatol. , vol.29 , pp. 495-501
    • James, O.F.W.1    Day, C.P.2
  • 2
    • 0028810805 scopus 로고
    • Prevalence of fatty liver in Japanese children and relationship to obesity: An epidemiological ultrasonographic survey
    • Ominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dis Dis Sci 1995;40:2002-2009.
    • (1995) Dis. Dis. Sci. , vol.40 , pp. 2002-2009
    • Ominaga, K.1    Kurata, J.H.2    Chen, Y.K.3
  • 3
    • 0034950652 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: Prediction of non-alcoholic steatohepatitis and liver fibrosis in severly obese
    • Dixon JB, Bharthal PS, O' Brien PE. Non-alcoholic fatty liver disease: prediction of non-alcoholic steatohepatitis and liver fibrosis in severly obese. Gastroenterology 2001;121:91-100.
    • (2001) Gastroenterology , vol.121 , pp. 91-100
    • Dixon, J.B.1    Bharthal, P.S.2    O' Brien, P.E.3
  • 4
    • 0037129380 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease
    • Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 5
    • 0036116213 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis (NASH): Where are we now and where are we going?
    • Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002;50: 585-588.
    • (2002) Gut , vol.50 , pp. 585-588
    • Day, C.P.1
  • 6
    • 0036841764 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: What we know in the new millennium
    • Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002;97:2714-2724.
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 2714-2724
    • Harrison, S.A.1    Kadakia, S.2    Lang, K.A.3
  • 7
    • 0031947715 scopus 로고    scopus 로고
    • Steatohepatitis - A tale of two "hits"?
    • Day CP, James OFW. Steatohepatitis - a tale of two "hits"? Gastroenterology 1998;114:842-845.
    • (1998) Gastroenterology , vol.114 , pp. 842-845
    • Day, C.P.1    James, O.F.W.2
  • 8
    • 0343314903 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatis and crytogenic cirrhosis within kindreds
    • Struben VMD, Hespenheide EE, Caldwell SH. Non-alcoholic steatohepatis and crytogenic cirrhosis within kindreds. Am J Med 2000;108:9-13.
    • (2000) Am. J. Med. , vol.108 , pp. 9-13
    • Struben, V.M.D.1    Hespenheide, E.E.2    Caldwell, S.H.3
  • 9
    • 0006168517 scopus 로고    scopus 로고
    • The genetic basis for non-alcoholic and alcoholic steatohepatitis
    • (NASH and SH). Dordrecht: Kluwer Academic Publishers, Falk Symposium No 121
    • Day CP. The genetic basis for non-alcoholic and alcoholic steatohepatitis. In: Steatohepatitis (NASH and SH). Dordrecht: Kluwer Academic Publishers, Falk Symposium No 121,2001;43-53.
    • (2001) Steatohepatitis , pp. 43-53
    • Day, C.P.1
  • 10
    • 0033516569 scopus 로고    scopus 로고
    • Peroxisomal and mitochondrial fatty acid (oxidation in mice nullizygous for both peroxisome proliferator-activated receptor (and peroxisomal fatty acyl-CoA oxidase
    • Hashimoto T, Tomoyuki F, Usuda N, et al. Peroxisomal and mitochondrial fatty acid (oxidation in mice nullizygous for both peroxisome proliferator-activated receptor (and peroxisomal fatty acyl-CoA oxidase. J Biol Chem 1999;274:19228-19236.
    • (1999) J. Biol. Chem. , vol.274 , pp. 19228-19236
    • Hashimoto, T.1    Tomoyuki, F.2    Usuda, N.3
  • 11
    • 0034713444 scopus 로고    scopus 로고
    • Roles of PPARs in health and disease
    • Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000;405:421-424.
    • (2000) Nature , vol.405 , pp. 421-424
    • Kersten, S.1    Desvergne, B.2    Wahli, W.3
  • 12
    • 0034046520 scopus 로고    scopus 로고
    • The human peroxisome proliferator-activated receptor (gene: Identification and functional characterization of two natural allelic variants
    • Sapone A, Peters JM, Sakai S, et al. The human peroxisome proliferator-activated receptor (gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 2000;10:321-323.
    • (2000) Pharmacogenetics , vol.10 , pp. 321-323
    • Sapone, A.1    Peters, J.M.2    Sakai, S.3
  • 13
    • 25044479065 scopus 로고    scopus 로고
    • y mice is associated with severe hepatic steatosis after treatment with antidiabetic thiazolidinediones
    • y mice is associated with severe hepatic steatosis after treatment with antidiabetic thiazolidinediones. Hepatology 2000;32:296A.
    • (2000) Hepatology , vol.32
    • Boelsterli, U.A.1    Bedoucha, M.2    Atzpodien, E.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.